CEBPA and metabolic dysfunction-associated steatotic liver disease: Transcription activators of FABP, PPAR alpha and FOXA1 (Fox-head Box protein A1) were reduced in NAFLD while its repressor CCAAT/enhancer-binding protein-alpha (C/EBPα) was induced or unchanged (Guzman et al., 2013[48]).